Latest News

Подпишитесь на нашу новостную ленту

Вопрос?

21.10.2026

Getinge Interim Report July-September 2026: Increased profitability, strong cash flow and higher customer satisfaction

"We delivered organic growth both in order intake and in sales during the quarter, at the same time we increased profitability and generated strong cash flow.” says Mattias Perjos, President & CEO of Getinge.

Нормативные документы

21.10.2026
Getinge Interim Report July-September 2026: Increased profitability, strong cash flow and higher customer satisfaction

15.10.2026

Nomination Committee appointed ahead of Getinge’s Annual General Meeting 2027

The members of the Nomination Committee for Getinge AB’s Annual General Meeting 2027 have now been appointed.

Нормативные документы

15.10.2026
Nomination Committee appointed ahead of Getinge’s Annual General Meeting 2027

The members of the Nomination Committee for Getinge AB’s Annual General Meeting 2027 have now been appointed.

13.10.2026

Getinge brings its smallest Edi catheter to the U.S. market following FDA clearance

New catheter extends NAVA-supported care to some of the smallest patients in neonatal intensive care, weighing between 500 and 1,000 grams.

Пресс-релиз

13.10.2026
Getinge brings its smallest Edi catheter to the U.S. market following FDA clearance

New catheter extends NAVA-supported care to some of the smallest patients in neonatal intensive care, weighing between 500 and 1,000 grams.

07.10.2026

Getinge announces departure of Eric Honroth, President Life Science

Getinge today announced that Eric Honroth will resign as President Life Science and member of the Executive Team to accept an external opportunity.

Нормативные документы

07.10.2026
Getinge announces departure of Eric Honroth, President Life Science

Getinge today announced that Eric Honroth will resign as President Life Science and member of the Executive Team to accept an external opportunity.

07.10.2026

Getinge invites fund managers, analysts, and media to Q3 Report 2026 conference call

Getinge will issue its Q3 Report 2026 on October 21, 2026, at 08.00 a.m. CEST, followed by a conference call at 10.00 a.m. CEST, hosted by Mattias Perjos, President & CEO, and Agneta Palmér, CFO.

Пресс-релиз

07.10.2026
Getinge invites fund managers, analysts, and media to Q3 Report 2026 conference call

Getinge will issue its Q3 Report 2026 on October 21, 2026, at 08.00 a.m. CEST, followed by a conference call at 10.00 a.m. CEST, hosted by Mattias Perjos, President & CEO, and Agneta Palmér, CFO.

25.09.2026

Insights from a fast-growing market

Over the past four years, Aruna Nayak has led Getinge’s operations in India through a period of strong growth, learning, and transformation.

Новости

25.09.2026
Insights from a fast-growing market

Over the past four years, Aruna Nayak has led Getinge’s operations in India through a period of strong growth, learning, and transformation.

Пресс-контакт

Caroline Örmgård

Head of Public & Media Relations
Tel: +46 10 335 0041

Alexandra Holland

Executive Vice President, Brand & Communications
Phone: +1 9737097000

Katarzyna Sypula,Senior CX Campaigns & Events Manager, Getinge

Katarzyna Sypuła

Senior Customer Experience Campaigns & Events Manager
CEE/ South Europe / SAPAC
Tel: +48 661 705 706

Предпочитаете связаться с нами онлайн?

Нажмите ниже, чтобы заполнить соответствующую форму. Мы свяжемся с вами в ближайшее время!

Заполните форму

Вы ищете

Галерея

Разнообразный формат изображений доступен для статей в прессе

Перейти в галерею

Man and woman looking a something together

О нас

Все, что вам нужно знать о Getinge одним взглядом

Узнайте больше о Getinge

Срочная коррекция медицинского оборудования

Добровольная срочная полевая коррекция медицинского устройства для внутриаортальной баллонной контрпульсации CARDIOSAVE (IABP)

Прочитать уведомление

Не пропустите ничего

Кликайте на иконки и подписывайтесь на нас!

Company Newsroom

Подпишитесь на нашу новостную ленту

Вопрос?

Getinge Interim Report July-September 2026: Increased profitability, strong cash flow and higher customer satisfaction

21.10.2026
Getinge Interim Report July-September 2026: Increased profitability, strong cash flow and higher customer satisfaction

Nomination Committee appointed ahead of Getinge’s Annual General Meeting 2027

15.10.2026
Nomination Committee appointed ahead of Getinge’s Annual General Meeting 2027

Getinge brings its smallest Edi catheter to the U.S. market following FDA clearance

13.10.2026
Getinge brings its smallest Edi catheter to the U.S. market following FDA clearance

Getinge announces departure of Eric Honroth, President Life Science

07.10.2026
Getinge announces departure of Eric Honroth, President Life Science

Getinge invites fund managers, analysts, and media to Q3 Report 2026 conference call